The predominate focus of an early stage Life Sciences on their path to commercialization is on two fronts. The first is on the scientific, technical, and regulatory areas of drug ...

With a slow, long, and regulated road to successful drug development, along with standard approval gates required for progression, the ...

Defining how your sales force will be organized is a critical task leading up to new pre-commercial product launch. Traditionally, ...

With much of the world focused on the response to COVID-19, many biopharmaceuticals are looking at new ways that they ...

On January 28, 2020, the highly anticipated final FDA gene therapy guidances were released. In total, 7 guidance documents were ...

The 2020 pharmaceutical trends reflect the broad shifts currently impacting the industry as it moves from the blockbuster model that ...

Numerous channels are competing for physician awareness now, making the process for modern drugmakers all the more challenging in fostering ...

Increased globalization and the growing complexities around innovative, next-generation therapies has forced biopharmaceutical leaders to reexamine their clinical supply chain ...

In the age of precision and personalized medicine, life science companies can develop treatments designed to target almost any patient’s ...

This client develops and produces treatment for life-threatening diseases around the world. In addition to antiviral and antiretroviral therapy used ...

The promising outlook for liquid biopsy diagnosis has sparked the interest of many in the biotech industry. The speed, ease, ...

A paper published this month proving that the use of RNA transposons can improve the CRISPR process has excited the ...